EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Potentials of Bioactive Compounds of the Essential Oil of Monodora myristica as Inhibitors of COX-2: A Molecular Docking and In Silico Toxicity Assessment for Anti-Inflammatory Properties

Afolabi Felix Olaide, Apata Joseph Tosin, Oyemitan Idris Ajayi, Elusiyan Christianah Abimbola, Afolabi Titilayo Oluwapamilerin, Akanmu Moses Atand

The Nigerian Journal of Pharmacy · 30.10.2025 · 59 (2) · 417-430

DOI: 10.51412/psnnjp.2025.42 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Nigerian Journal of Pharmacy, online erschienen am 30.10.2025. Verfasst von Afolabi Felix Olaide und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The seed extract from Monodora myristica has traditionally been employed in antiinflammatory therapies. In light of the escalating costs and side effects associated with existing drugs for managing inflammatory conditions, the pursuit of potential novel pharmacological agent is imperative. Cyclooxygenase, especially the COX-2 isoform, emerges as a key target owing to its critical involvement in inflammatory processes.

Methods

This investigation utilized computational modeling techniques to evaluate the binding affinities and interaction profiles of compounds derived from the dried seeds essential oil of Monodora myristica with COX-2.

Results

The leading three compounds exhibited binding affinities between -6.7 and -6.9 kcal/mol, which were notably superior to those of the reference ligands [diclofenac (–6.6 kcal/mol) and ibuprofen (-6.8 kcal/mol)]. Notably, naphthalene (-6.9 kcal/mol) and 2,3,5,6-tetramethylphenol (-6.9 kcal/mol) demonstrated the highest binding affinities, indicating their promise as COX-2 inhibitors. ADMET profiling revealed favorable physicochemical and pharmacodynamic characteristics for these compounds.

Conclusion

This study advances the field of innovative anti-inflammatory drug development and establishes a foundation for subsequent research on precision-targeted strategies against inflammatory disorders.

Zitieren

APA

Olaide, A. F., Tosin, A. J., Ajayi, O. I., Abimbola, E. C., Oluwapamilerin, A. T., & Atand, A. M. (2025). Potentials of Bioactive Compounds of the Essential Oil of Monodora myristica as Inhibitors of COX-2: A Molecular Docking and In Silico Toxicity Assessment for Anti-Inflammatory Properties. The Nigerian Journal of Pharmacy, 59(2), 417-430. https://doi.org/10.51412/psnnjp.2025.42

Vancouver

Olaide AF, Tosin AJ, Ajayi OI, Abimbola EC, Oluwapamilerin AT, Atand AM. Potentials of Bioactive Compounds of the Essential Oil of Monodora myristica as Inhibitors of COX-2: A Molecular Docking and In Silico Toxicity Assessment for Anti-Inflammatory Properties. The Nigerian Journal of Pharmacy. 2025;59(2):417-430. doi:10.51412/psnnjp.2025.42

BibTeX
@article{Olaide2025,
  author = {Olaide, Afolabi Felix and Tosin, Apata Joseph and Ajayi, Oyemitan Idris and Abimbola, Elusiyan Christianah and Oluwapamilerin, Afolabi Titilayo and Atand, Akanmu Moses},
  title = {Potentials of Bioactive Compounds of the Essential Oil of Monodora myristica as Inhibitors of COX-2: A Molecular Docking and In Silico Toxicity Assessment for Anti-Inflammatory Properties},
  journal = {The Nigerian Journal of Pharmacy},
  year = {2025},
  volume = {59},
  number = {2},
  pages = {417--430},
  doi = {10.51412/psnnjp.2025.42}
}
Kostenlos starten →